Market Cap (In CAD)
82.34 Million
Revenue (In CAD)
-
Net Income (In CAD)
-5.21 Million
Avg. Volume
16.04 Thousand
- Currency
- CAD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.28-0.92
- PE
- -22.0
- EPS
- -0.05
- Beta Value
- 0.095
- ISIN
- CA3686501071
- CUSIP
- -
- CIK
- -
- Shares
- 74863500.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Brian Firth
- Employee Count
- -
- Website
- https://www.geminalabs.com
- Ipo Date
- 2021-08-12
- Details
- Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. The company develops novel surface functionalization chemistries for the detection of pathogens and biomarkers. It is developing POC Antigen COVID test, a point-of-care lateral flow assay test strip to test whether or not a person is currently infected with COVID-19. The company is headquartered in Vancouver, Canada.
More Stocks
-
JTCJTC PLC
JTC
-
KRKNP
-
WLLBWChord Energy Corporation
WLLBW
-
MAANALUMaan Aluminium Limited
MAANALU
-
BANCOINDIABanco Products (India) Limited
BANCOINDIA
-
CARDCard Factory plc
CARD
-
ALLSECAllsec Technologies Limited
ALLSEC
-
ORAAFAura Minerals Inc.
ORAAF